Protecting the endothelial glycocalyx in COVID-19
COVID-19 is a respiratory infection caused by the highly transmissible SARS-CoV-2. While most infected patients exhibit mild to moderate symptoms, a minority may develop severe vascular damage, which can be fatal. One example of this damage is disruption to the endothelial glycocalyx (EG) layer. EG...
Main Authors: | Tay, Emira Adam, Vijayakumar, Vimmal, Morales, Raika Francesca, Lee, Ee Soo, Teo, Andrew |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/178900 |
Similar Items
-
Hyaluronidase-1-mediated glycocalyx impairment underlies endothelial abnormalities in polypoidal choroidal vasculopathy
by: Wu, Kan Xing, et al.
Published: (2022) -
Endothelial pathophysiology, glycosaminoglycans and glycocalyx
by: Luca Masotti
Published: (2015-10-01) -
Markers of the Endothelial Glycocalyx Are Improved following Kidney Transplantation
by: Hui Liew, et al.
Published: (2021-07-01) -
Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction
by: Hui Liew, et al.
Published: (2021-01-01) -
Inflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody
by: Lee, Ee-Soo, et al.
Published: (2024)